iTeos Therapeutics Stock Quote ITOS - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

10.99

Bid

4.40

Ask

17.00

Volume

0.00 Day's Range 0.00

8.20 52 Week Range 18.24

Market Cap

393.916M

Previous Close

10.99

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

290,257

Shares Outstanding

35,843,131

Dividend Yield

PE Ratio

-3.50

Earnings Per Share (EPS)

-3.14

Revenue

12.6M

Net Profit

-112.64M

ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoin... ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.iteostherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

iTeos Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ITOS. The last closing price for iTeos Therapeutics was $10.99. Over the last year, iTeos Therapeutics shares have traded in a share price range of $ 8.20 to $ 18.24.

iTeos Therapeutics currently has 35,843,131 shares outstanding. The market capitalization of iTeos Therapeutics is $393.92 million. iTeos Therapeutics has a price to earnings ratio (PE ratio) of -3.50.

iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024

WATERTOWN, Mass. and GOSSELIES, Belgium, April 07, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.16	-1.43497757848	11.15	11.215	10.01	366676	10.64029754	CS
4	-1.74	-13.6684996072	12.73	13.8	10.01	319504	12.16551495	CS
12	1.04	10.4522613065	9.95	13.8	9.7	290257	11.32457053	CS
26	1.91	21.0352422907	9.08	13.8	8.7301	304076	10.74629063	CS
52	-2.76	-20.0727272727	13.75	18.24	8.2	360408	11.79354845	CS
156	-13.04	-54.2655014565	24.03	52.43	8.2	364521	21.48372188	CS
260	-8.71	-44.2131979695	19.7	52.43	8.2	333465	22.6445757	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CSSEChicken Soup for the Soul Entertainment Inc	$ 0.2429 (59.49%)	8.67M
ZPTAZapata Computing Holdings Inc	$ 2.09 (33.97%)	3.85M
IMCCIM Cannabis Corporation	$ 0.7268 (27.44%)	3
VIVKVivakor Inc	$ 1.86 (25.68%)	100
TSLRGraniteShares ETF Trust GraniteShares	$ 10.05 (23.92%)	3.05k
EVOEvotec SE	$ 5.02 (-34.38%)	90.4k
ESCAEscalade Inc	$ 10.35 (-24.78%)	10
TSLZT Rex 2X Inverse Tesla Daily Target ETF	$ 42.46 (-24.07%)	235.83k
TSDDGraniteShares ETF Trust GraniteShares	$ 27.14 (-23.55%)	19.98k
BJDXBluejay Diagnostics Inc	$ 0.50 (-20.00%)	800
CSSEChicken Soup for the Soul Entertainment Inc	$ 0.2429 (59.49%)	8.67M
CYNCYNGN Inc	$ 0.1177 (3.25%)	6.93M
ZPTAZapata Computing Holdings Inc	$ 2.09 (33.97%)	3.85M
PEGYPineapple Energy Inc	$ 0.0582 (2.83%)	3.79M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 6.665 (23.65%)	2.96M